Discontinuation report INTRON A
| Report ID | 18629 |
| Drug Identification Number | 02231651 |
| Brand name | INTRON A |
| Common or Proper name | interferon alfa-2b lyophilized powder |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | |
| Strength(s) | |
| Dosage form(s) | |
| Route of administration | |
| Packaging size | Kit, Liquid, Powder For Solution |
| ATC code | |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-08-09 |
| Remaining supply date | 2017-08-09 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-08-10 | English | Compare |
| v4 | 2017-08-09 | French | Compare |
| v3 | 2017-08-09 | English | Compare |
| v2 | 2017-08-09 | French | Compare |
| v1 | 2017-08-09 | English | Compare |
Showing 1 to 5 of 5